1. |
Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation, 2002, 106(24): 3006-3008.
|
2. |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021, 143(5): e35-e71.
|
3. |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease: Developed by the Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed), 2022, 75(6): 524.
|
4. |
潘文志, 周达新, 葛均波. 最新经导管主动脉瓣置换器械的研发与创新. 中国医刊, 2020, 55(1): 8-11.
|
5. |
Rotman OM, Bianchi M, Ghosh RP, et al. Principles of TAVR valve design, modelling, and testing. Expert Rev Med Devices, 2018, 15(11): 771-791.
|
6. |
Shi J, Wei L, Chen Y, et al. Transcatheter aortic valve implantation with J-valve: 2-year outcomes from a multicenter study. Ann Thorac Surg, 2021, 111(5): 1530-1536.
|
7. |
Jayasuriya C, Moss RR, Munt B. Transcatheter aortic valve implantation in aortic stenosis: The role of echocardiography. J Am Soc Echocardiogr, 2011, 24(1): 15-27.
|
8. |
Fernandes P, Cleland A, Bainbridge D, et al. Development of our TAVI protocol for emergency initiation of cardiopulmonary bypass. Perfusion, 2015, 30(1): 34-39.
|
9. |
Bavaria JE, Tommaso CL, Brindis RG, et al. 2018 AATS/ACC/SCAI/STS expert consensus systems of care document: Operator and institutional recommendations and requirements for transcatheter aortic valve replacement: A joint report of the American Association for Thoracic Surgery, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol, 2019, 73(3): 340-374.
|
10. |
周达新, 潘文志, 吴永健, 等. 经导管主动脉瓣置换术中国专家共识(2020更新版). 中国介入心脏病学杂志, 2020, 28(6): 301-309.
|
11. |
"心尖入路经导管主动脉瓣植入术麻醉管理规范"工作组. 心尖入路经导管主动脉瓣植入术麻醉管理规范. 中华麻醉学杂志, 2021, 41(2): 133-137.
|
12. |
Sullivan BL, Bartels K, Hamilton N. Insertion and management of temporary pacemakers. Semin Cardiothorac Vasc Anesth, 2016, 20(1): 52-62.
|
13. |
Rodés-Cabau J, Ellenbogen KA, Krahn AD, et al. Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC Scientific Expert Panel. J Am Coll Cardiol, 2019, 74(8): 1086-1106.
|
14. |
Lilly SM, Deshmukh AJ, Epstein AE, et al. 2020 ACC expert consensus decision pathway on management of conduction disturbances in patients undergoing transcatheter aortic valve replacement: A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol, 2020, 76(20): 2391-2411.
|
15. |
Banks A, Gaca J, Kiefer T. Review of alternative access in transcatheter aortic valve replacement. Cardiovasc Diagn Ther, 2020, 10(1): 72-82.
|
16. |
McInerney A, Vera-Urquiza R, Tirado-Conte G, et al. Pre-dilation and post-dilation in transcatheter aortic valve replacement: Indications, benefits and risks. Interv Cardiol, 2021, 16: e28.
|
17. |
Thourani VH, Jensen HA, Babaliaros V, et al. Transapical and transaortic transcatheter aortic valve replacement in the United States. Ann Thorac Surg, 2015, 100(5): 1718-1726.
|
18. |
Fassa AA, Himbert D, Vahanian A. Mechanisms and management of TAVR-related complications. Nat Rev Cardiol, 2013, 10(12): 685-695.
|
19. |
Gerckens U, Tamburino C, Bleiziffer S, et al. Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study. Eur Heart J, 2017, 38(36): 2729-2738.
|
20. |
Wendler O, Schymik G, Treede H, et al. SOURCE 3registry: Design and 30-day results of the european postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve. Circulation, 2017, 135(12): 1123-1132.
|
21. |
Sinning JM, Vasa-Nicotera M, Chin D, et al. Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol, 2013, 62(1): 11-20.
|
22. |
Eleid MF, Cabalka AK, Malouf JF, et al. Techniques and outcomes for the treatment of paravalvular leak. Circ Cardiovasc Interv, 2015, 8(8): e001945.
|
23. |
Pollari F, Dell’Aquila AM, Söhn C, et al. Risk factors for paravalvular leak after transcatheter aortic valve replacement. J Thorac Cardiovasc Surg, 2019, 157(4): 1406-1415.
|
24. |
Fanous EJ, Mukku RB, Dave P, et al. Paravalvular leak assessment: Challenges in assessing severity and interventional approaches. Curr Cardiol Rep, 2020, 22(12): 166.
|
25. |
Aguirre J, Waskowski R, Poddar K, et al. Transcatheter aortic valve replacement: Experience with the transapical approach, alternate access sites, and concomitant cardiac repairs. J Thorac Cardiovasc Surg, 2014, 148(4): 1417-1422.
|
26. |
Tabata M. Transapical approach in transcatheter cardiovascular interventions. Gen Thorac Cardiovasc Surg, 2018, 66(4): 185-191.
|
27. |
Mach M, Okutucu S, Kerbel T, et al. Vascular complications in TAVR: Incidence, clinical impact, and management. J Clin Med, 2021, 10(21): 5046.
|
28. |
Heitkemper M, Hatoum H, Azimian A, et al. Modeling risk of coronary obstruction during transcatheter aortic valve replacement. J Thorac Cardiovasc Surg, 2020, 159(3): 829-838.
|
29. |
Palmerini T, Chakravarty T, Saia F, et al. Coronary protection to prevent coronary obstruction during TAVR: A multicenter international registry. JACC Cardiovasc Interv, 2020, 13(6): 739-747.
|
30. |
Qian H, Chen Y, Cheng Z, et al. An alternative solution for patient with high risk of coronary obstruction underwent TAVI procedure using a novel second-generation device—A case series. J Cardiothorac Surgy, 2019, 14: 1-3.
|
31. |
Ye J, Lee A J, Blanke P, et al. The first transapical transcatheter aortic valve‐in‐valve implantation using the J‐valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction. Catheter Cardiovasc Interv, 2018, 92(6): 1209-1214.
|
32. |
Valvo R, Costa G, Barbanti M. How to avoid coronary occlusion during TAVR valve-in-valve procedures. Front Cardiovasc Med, 2019, 6: 168.
|
33. |
Tchetche D, Farah B, Misuraca L, et al. Cerebrovascular events post-transcatheter aortic valve replacement in a large cohort of patients: A FRANCE-2 registry substudy. JACC Cardiovasc Interv, 2014, 7(10): 1138-1145.
|
34. |
Ghatak A, Bavishi C, Cardoso RN, et al. Complications and mortality in patients undergoing transcatheter aortic valve replacement with Edwards SAPIEN & SAPIEN XT valves: A meta‐analysis of world‐wide studies and registries comparing the transapical and transfemoral accesses. J Interv Cardiol, 2015, 28(3): 266-278.
|
35. |
Lowenstern A, Hung A, Manandhar P, et al. Association of transcatheter aortic valve replacement reimbursement, new technology add-on payment, and procedure volumes with embolic protection device use. JAMA Cardiol, 2022, 7(9): 945-952.
|
36. |
Rubín JM, Avanzas P, del Valle R, et al. Atrioventricular conduction disturbance characterization in transcatheter aortic valve implantation with the CoreValve prosthesis. Circ Cardiovasc Interv, 2011, 4(3): 280-286.
|
37. |
Aljabbary T, Qiu F, Masih S, et al. Association of clinical and economic outcomes with permanent pacemaker implantation after transcatheter aortic valve replacement. JAMA Netw Open, 2018, 1(1): e180088.
|
38. |
Tung M, Wang X, Li F, et al. A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system. J Cardiol, 2018, 72(5): 377-384.
|
39. |
Vallabhajosyula S, Patlolla SH, Sandhyavenu H, et al. Periprocedural cardiopulmonary bypass or venoarterial extracorporeal membrane oxygenation during transcatheter aortic valve replacement: A systematic review. J Am Heart Assoc, 2018, 7(14): e009608.
|